David Reiter has become vice president, general counsel, and corporate secretary of Luminex. Reiter was previously general counsel for 724 Solutions and senior counsel for Compaq Computer.
Eclipse Diagnostics, Large Scale Biology’s new diagnostics subsidiary that plans to market mass spec-based pattern recognition technology, announced its management team. Kevin Ryan, president and CEO of LSBC, will also serve as Eclipse’s president. He holds a bachelor’s degree in business and marketing from the University of Notre Dame. John Rakitan will be the company’s senior vice president and general manager, in addition to being senior vice president, general counsel, and secretary at LSBC. Rakitan holds a JD from the University of Notre Dame and a BS in biology from Northern Illinois University. Gary Wolfe will serve as Eclipse’s senior vice president and CSO. Wolfe received a BS in chemistry from the University of California, Los Angeles, and a PhD in physical chemistry from the University of Washington. Guy della Cioppa will be the company’s senior vice president for business development. He joins Eclipse from NanoInk, where he was executive vice president of business development. He holds a PhD in biology from the University of California, Los Angeles. Ronal Artale will serve as the company’s senior vice president and CFO. He is also senior vice president, COO, and CFO at LSBC. Artale holds an MBA in finance from St. John’s University. Additionally, John Chute has been appointed to Eclipse’s scientific advisory board. He is a hematologist-oncologist and an associate professor at the Duke University Medical Center. Prior to that, he was vice president for medical affairs at LSBC. Chute holds an undergraduate degree from the University of Notre Dame and a medical degree from Georgetown University School of Medicine.
Shamrock Structures of Woodrige, Ill., has appointed the following scientific advisory board: Michael Johnson, a professor of medicinal chemistry and pharmacognosy at the University of Illinois at Chicago (UIC); Richard Morimoto, a professor of biology at Northwestern University; Andrew Mesecar, an assistant professor of medicinal chemistry and pharmacognosy at UIC; Bernard Santarsiero, a research professor at UIC and a co-founder of Syrrx; and Richard van Breemen, a professor of medicinal chemistry and pharmacognosy at UIC. In addition, Steven Schiltz has become CEO and Cheryl Janson has been named director of protein crystallization of the company.